Abortifacient Agents, Nonsteroidal
"Abortifacient Agents, Nonsteroidal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Non-steroidal chemical compounds with abortifacient activity.
| Descriptor ID |
D000020
|
| MeSH Number(s) |
D27.505.696.875.131.100 D27.505.954.705.131.100
|
| Concept/Terms |
Abortifacient Agents, Nonsteroidal- Abortifacient Agents, Nonsteroidal
- Agents, Nonsteroidal Abortifacient
- Nonsteroidal Abortifacient Agents
- Abortifacient Agents, Non-Steroidal
- Abortifacient Agents, Non Steroidal
- Agents, Non-Steroidal Abortifacient
- Non-Steroidal Abortifacient Agents
|
Below are MeSH descriptors whose meaning is more general than "Abortifacient Agents, Nonsteroidal".
Below are MeSH descriptors whose meaning is more specific than "Abortifacient Agents, Nonsteroidal".
This graph shows the total number of publications written about "Abortifacient Agents, Nonsteroidal" by people in this website by year, and whether "Abortifacient Agents, Nonsteroidal" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 1 | 1 | 2 |
| 2018 | 2 | 3 | 5 |
| 2019 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Abortifacient Agents, Nonsteroidal" by people in Profiles.
-
Women's experiences of a telemedicine abortion service (up to 12 weeks) implemented during the coronavirus (COVID-19) pandemic: a qualitative evaluation. BJOG. 2021 10; 128(11):1752-1761.
-
Expansion of a direct-to-patient telemedicine abortion service in the United States and experience during the COVID-19 pandemic. Contraception. 2021 07; 104(1):43-48.
-
Increase rate of ruptured tubal ectopic pregnancy during the COVID-19 pandemic. Eur J Obstet Gynecol Reprod Biol. 2021 Apr; 259:95-99.
-
Medical Treatment for Ectopic Pregnancy during the COVID-19 Pandemic. Rev Bras Ginecol Obstet. 2020 12; 42(12):849-850.
-
COVID-19 impact in abortions' practice, a regional French evaluation. J Gynecol Obstet Hum Reprod. 2021 May; 50(5):102038.
-
Misoprostol in the era of COVID-19: a love letter to the original medical abortion pill. Sex Reprod Health Matters. 2020 12; 28(1):1829406.
-
Commentary: No-test medication abortion: A sample protocol for increasing access during a pandemic and beyond. Contraception. 2020 06; 101(6):361-366.
-
Management of first-trimester miscarriage: a systematic review and network meta-analysis. Hum Reprod Update. 2019 05 01; 25(3):362-374.
-
Sublingual vs vaginal misoprostol for completion of first trimester missed abortion: a randomised controlled trial. Eur J Contracept Reprod Health Care. 2019 Apr; 24(2):134-139.
-
Methotrexate Therapy for Ectopic Pregnancies: A Tertiary Center Experience. Rev Bras Ginecol Obstet. 2018 Nov; 40(11):680-685.